Clinical data | |
---|---|
Trade names | Didrex, Recede |
Other names | Benzfetamine; d-Benzphetamine; (+)-Benzphetamine; (S)-(+)-Benzphetamine; (S)-Benzphetamine; (2S)-N-Benzyl-N-methylamphetamine; dextro-N-Benzyl-N-methylamphetamine; N-Benzyldextromethamphetamine; (+)-N-Benzyl-N,α-dimethylphenethylamine |
AHFS/Drugs.com | Professional Drug Facts |
License data | |
Dependence liability | High[1] |
Routes of administration | By mouth |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 75–99% |
Metabolites | • Dextromethamphetamine • Dextroamphetamine |
Elimination half-life | 4–6 hours[3] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C17H21N |
Molar mass | 239.362 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Benzphetamine, sold under the brand name Didrex among others, is an amphetamine-type stimulant and appetite suppressant used short-term for weight loss along with a doctor-approved, reduced-calorie diet, exercise, and behavioral program. It is prescribed for obesity to people who have been unable to lose weight through exercise and dieting alone. It is a prodrug of dextromethamphetamine and dextroamphetamine.[4][5][6]
It primarily promotes weight loss through reduced appetite, but also slightly increases metabolism.[citation needed]
Woo2015
was invoked but never defined (see the help page).